Somalogic stock.

SomaLogic is a leading commercial-stage proteomics company. On October 4, 2023, Standard BioTools and SomaLogic announced a merger whereby Standard BioTools will issue new shares of stock to existing SomaLogic shareholders. After the merger, which is expected to close in early 2024, current Standard BioTools shareholders will own 43% of the ...

Somalogic stock. Things To Know About Somalogic stock.

Get the latest SomaLogic, Inc. (SLGC) stock quote, history, news and other vital information to help you with your stock trading and investing. See the performance outlook, earnings date, dividend yield, market cap, beta, PE ratio, EPS and more. Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. finance.yahoo.com - November 12 at 9:33 AM.of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited CLIA laboratory. SomaLogic saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 7,810,000 shares, a drop of 1.1% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.

Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …

Appointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the …If you hold stock certificates in your name, please contact our transfer agent, Continental, at 1-877-634-5370. ... Does SomaLogic have a direct stock purchase plan? Standard BioTools and SomaLogic to Combine in All-Stock Merger Creating a Diversified Leader in Life Sciences Tools. GlobeNewswire 61d. Start Trading >> Plus500. 81% of retail CFD accounts lose money.SomaLogic, Inc. : News, information and stories for SomaLogic, Inc. | Börse Stuttgart: 76X0 | Börse Stuttgart

Nov 30, 2023 · SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...

Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …

Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...SomaLogic saw a drop in short interest in the month of October. As of October 31st, there was short interest totaling 7,810,000 shares, a drop of 1.1% from the previous total of 7,900,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment.According to 4 stock analysts, the average 12-month stock price forecast for SomaLogic stock is $4.70, which predicts an increase of 66.67%. The lowest target is $2.30 and the highest is $7.00. On average, analysts rate SomaLogic stock as a buy.Aug 15, 2022 · SomaLogic Reports Second Quarter 2022 Financial Results. August 15, 2022 at 4:05 PM EDT. PDF Version. Second quarter 2022 revenue of $14.1 million, bringing year to date revenue to $37.1 million. Reducing 2022 revenue guidance to $80-90 million to account for ongoing variability in core service business, macroeconomic and commercial factors. SomaLogic (NASDAQ:SLGCW) and Aclarion (NASDAQ:ACONW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, media sentiment, valuation, earnings, analyst recommendations, dividends, institutional ownership, community ranking and risk.Founders David Brunel, Larry Gold. Operating Status Active. Last Funding Type Post-IPO Equity. Legal Name SomaLogic, Inc. Stock Symbol FRA:76X0. Company Type For Profit. Contact Email [email protected]. Phone Number 303-625-9000. SomaLogic operates as a protein biomarker discovery and clinical diagnostics company.

SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in …SomaLogic shareholders will receive 1.11 shares of Standard BioTools common stock for each share of SomaLogic common stock owned. Upon the close of the deal, Standard BioTools shareholders will ...Headline. SomaLogic Inc Class A. morningstar.com - November 22 at 6:40 PM. With 54% ownership of the shares, SomaLogic, Inc. (NASDAQ:SLGC) is heavily dominated by institutional owners. finance.yahoo.com - November 22 at 1:39 PM. SomaLogic, Inc. (NASDAQ:SLGC) Q3 2023 Earnings Call Transcript. finance.yahoo.com - November 12 at 9:33 AM.Mar 28, 2023 · SomaLogic, Inc. is a commercial-stage proteomics company. The Company has built an integrated proteomics platform, which offers throughput proteomics analysis with broad proteome coverage. It develops slow off-rate modified aptamers (SOMAmers), which are modified nucleic acid-based protein binding reagents that are specific for their cognate ... In conjunction with the announcement, Standard Bio raised its full-year guidance to $100M–$105M, while SomaLogic reaffirmed its 2023 guidance at $80M–$84M. More on Standard Bio, SomaLogic, etc.Mar 15, 2023 · And there's no doubt that SomaLogic, Inc. (NASDAQ:SLGC) stock has had a really bad year. In that relatively short period, the share price has plunged 69%. Because SomaLogic hasn't been listed for ... Are hedge funds shorting SomaLogic (NASDAQ:SLGCW) stock? View the latest SLGCW short interest ratio, short volume, and more at MarketBeat. Skip to main content. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. The bottom is in for this beaten-down retailer. Secure your stake in the Smart Home industry.

Are hedge funds shorting SomaLogic (NASDAQ:SLGCW) stock? View the latest SLGCW short interest ratio, short volume, and more at MarketBeat. Skip to main content. S&P 500 4,559.34. DOW 35,390.15. QQQ 389.51. The bottom is in for this beaten-down retailer. Secure your stake in the Smart Home industry.

If you’re just getting started, tracking investments might seem like a mystery. Thankfully, modern tools and technology make it easier than ever to figure out how to manage your stock portfolio and to track it. This quick guide gives you ti...THIS NON-QUALIFIED STOCK OPTION AWARD AGREEMENT (this “Agreement”), dated as of the Grant Date specified above, is entered into by and between SomaLogic, Inc., a Delaware corporation (the “Company”), and the Participant specified above, pursuant to the SomaLogic, Inc. 2021 Omnibus Incentive Plan, as in effect and as amended from time …SomaLogic is a protein biomarker discovery and clinical diagnostics company located in Boulder, Colorado. It became listed on Nasdaq in September 2021 with a merger with the special-purpose acquisition company CM Life Sciences II, Inc. [2]Understanding stock price lookup is a basic yet essential requirement for any serious investor. Whether you are investing for the long term or making short-term trades, stock price data gives you an idea what is going on in the markets.What is the target price for SomaLogic (SLGC) stock? The latest price target for SomaLogic ( NASDAQ: SLGC) was reported by Jefferies on Thursday, October 5, 2023. The analyst firm set a price ... Stocks trading online may seem like a great way to make money, but if you want to walk away with a profit rather than a big loss, you’ll want to take your time and learn the ins and outs of online investing first. This guide should help get...SOUTH SAN FRANCISCO, Calif. and BOULDER, Colo., Dec. 04, 2023 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq: LAB), driven by a bold …

Under the terms of the all-stock deal, SomaLogic investors are to receive 1.11 common shares of Standard BioTools stock for each SomaLogic common share they hold. When the merger closes, SomaLogic ...

SomaLogic and Standard BioTools announced on Wednesday that the companies would combine in an all-stock merger. The combined company will have a pro forma equity value of over $1 billion.

Mar 28, 2023 · SomaLogic Reports Fourth Quarter and Full Year 2022 Financial Results, Announces Director Appointments and Management Evolution. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized ... Appointed Eliot Lurier, CPA, to Interim Chief Financial Officer. Second Quarter 2023 Financial Results. Revenue for the three months ended June 30, 2023 was $20.5 million, a 45% increase from $14.1 million in the corresponding period of 2022. Excluding Q2 2022 royalty revenue from NEB, revenue grew 55%. Gross margin for the three months ended ...of SomaLogic Operating Co., Inc. and any third-party trademarks used herein are the property of their respective owners. For Research Use Only (RUO). Not intended for diagnostic or patient management purposes. Somalogic Co. Inc. is certified to ISO 9001:2015, accredited to ISO 27001:2013 and ISO 15189:2012, and is a CAP-accredited …What is the target price for SomaLogic (SLGC) stock? The latest price target for SomaLogic ( NASDAQ: SLGC) was reported by Jefferies on Thursday, October 5, 2023. The analyst firm set a price ... Approximate date of commencement of proposed sale to the public: As soon as practicable after this registration statement becomes effective and all other conditions to the transactions contemplated by the Merger Agreement described in the included proxy statement/prospectus have been satisfied or waived.. If the securities being registered on …Information concerning SomaLogic’s directors and executive officers, including their ownership of SomaLogic securities, is set forth in the joint proxy …SomaLogic's stock was trading at $0.40 on January 1st, 2023. Since then, SLGCW shares have decreased by 65.0% and is now trading at $0.14. View the best growth stocks for 2023 here. This page (NASDAQ:SLGCW) was last updated on 10/12/2023 by MarketBeat.com Staff. Get 30 Days of MarketBeat All Access Free.SomaLogic, Inc. Class A Common Stock (SLGC) Stock Quotes - Nasdaq offers stock quotes & market activity data for US and global markets.SomaLogic will host a conference call at 4:30 p.m. ET on Thursday, May 12, 2022, to discuss its first quarter 2022 financial results. ... Preferred stock, $0.0001 par value; 1,000,000 shares authorized; no shares issued and outstanding at March 31, ...

Income Statement for Somalogic Inc (SLGC) with Annual and Quarterly reports. Income Statement for Somalogic Inc (SLGC) ... Stock Market Overview Market Momentum Market Performance Top 100 Stocks Today's Price Surprises New Highs & Lows Economic Overview Earnings Within 7 Days Earnings & Dividends Stock Screener.Planned merger with SomaLogic activates strategic M&A thesis. SOUTH SAN FRANCISCO, Calif., Nov. 07, 2023 (GLOBE NEWSWIRE) -- BioTools Inc. (“SBI” or the “Company”) (Nasdaq: LAB), driven by ...Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...Nov 24, 2023 · SomaLogic's stock surges as it agrees to be bought by Standard BioTools in all-stock merger. SomaLogic Inc.'s SLGC, -2.54% stock was up about 12% in premarket trades on Wednesday after the Boulder, Colo.-based specialist in cell proteins agreed to be acquired in an all-stock merger with Stand... Instagram:https://instagram. algm stock forecastwhat's the best health insurance for self employed2070 target date retirement fundbest health insurance in oregon Summary of all time highs, changes and price drops for SomaLogic; Historical stock prices; Current Share Price: US$2.71: 52 Week High: US$3.79: 52 …SomaLogic will host a conference call at 4:30 p.m. ET on Monday, August 14, 2023 to discuss its second quarter 2023 financial results. Those interested in listening to the conference call should ... invest in art sharesbest mobile insurance Medpace Holdings, Inc. (NASDAQ:MEDP) released its quarterly earnings results on Monday, October, 23rd. The company reported $2.22 EPS for the quarter, beating analysts' consensus estimates of $2.05 by $0.17. The business earned $492.50 million during the quarter, compared to analysts' expectations of $475.79 million. stock dips Upon the terms and subject to the conditions set forth in the Merger Agreement, at the effective time of the Merger, each share of common stock, par value $0.0001 per share, of SomaLogic issued and outstanding (“SomaLogic Stock”) will be converted into the right to receive 1.11 (the “Exchange Ratio”) shares of common stock, par value $0 ...SomaLogic Inc Class A SLGC Morningstar Rating Stock XNAS Rating as of Nov 21, 2023 Summary Chart News Price vs Fair Value Sustainability Trailing Returns Financials Valuation Operating...SLGC Sales Forecast. Next quarter’s sales forecast for SLGC is $21.05M with a range of $20.60M to $21.60M. The previous quarter’s sales results were $22.05M. SLGC beat its sales estimates 100.00% of the time in past 12 months, while its overall industry beat sales estimates 45.92% of the time in the same period.